ABBVAbbVie

Health care · Pharmaceuticals · NYSE

ABBV and 9 peers, year by year

The 9 Health care companies closest to ABBV in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

5 years 10 years Download CSV

Choose the peers

Each company's latest fiscal year
Company	Year	Revenue	Sales growth	Gross margin	Operating margin	Net margin	FCF margin	Return on equity	Debt / equity
ABBV AbbVie	FY2025	$61.2B	+8.6%	-	24.6%	6.9%	29.1%	n/m	n/m
MRK Merck & Co.	FY2025	$65.0B	+1.3%	-	-	28.1%	19.0%	34.7%	0.94
PFE Pfizer	FY2025	$62.6B	−1.6%	-	-	12.4%	14.5%	9.0%	0.75
HCA HCA Healthcare	FY2025	$75.6B	+7.1%	-	-	9.0%	10.2%	n/m	n/m
BMY Bristol Myers Squibb	FY2025	$48.2B	−0.2%	-	-	14.6%	26.7%	38.2%	2.55
ABT Abbott Laboratories	FY2025	$44.3B	+5.7%	-	18.2%	14.7%	16.7%	12.5%	0.25
TMO Thermo Fisher Scientific	FY2025	$44.6B	+3.9%	-	17.4%	15.0%	14.1%	12.6%	0.80
LLY Eli Lilly	FY2025	$65.2B	+44.7%	-	-	31.7%	-	77.8%	1.54
AMGN Amgen	FY2025	$36.8B	+10.0%	-	24.7%	21.0%	22.0%	89.1%	6.31
MDT Medtronic	FY2026	$36.4B	+8.4%	-	17.8%	13.2%	14.9%	9.7%	0.57

Revenuepeer median $48.2B

Sales growthpeer median +5.7%

Operating marginpeer median 18.0%

AMGN 24.7%
ABBV 24.6%
ABT 18.2%
MDT 17.8%
TMO 17.4%
MRK -
PFE -
HCA -
BMY -
LLY -

Net marginpeer median 14.7%

FCF marginpeer median 15.8%

Return on equitypeer median 23.6%

Debt / equitypeer median 0.87

AMGN 6.31
BMY 2.55
LLY 1.54
MRK 0.94
TMO 0.80
PFE 0.75
MDT 0.57
ABT 0.25
ABBV n/m
HCA n/m

RevenueSales growthGross marginOperating marginNet marginFree cash flowFCF marginReturn on equityDebt / equityEPS (diluted)

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	$25.6B	$28.2B	$32.8B	$33.3B	$45.8B	$56.2B	$58.1B	$54.3B	$56.3B	$61.2B
MRK Dec	$39.8B	$40.1B	$42.3B	$39.1B	$41.5B	$48.7B	$59.3B	$60.1B	$64.2B	$65.0B
PFE Dec	$52.8B	$52.5B	$40.8B	$40.9B	$41.7B	$81.3B	$101.2B	$59.6B	$63.6B	$62.6B
HCA Dec	$41.5B	$43.6B	$46.7B	$51.3B	$51.5B	$58.8B	$60.2B	$65.0B	$70.6B	$75.6B
BMY Dec	$19.4B	$20.8B	$22.6B	$26.1B	$42.5B	$46.4B	$46.2B	$45.0B	$48.3B	$48.2B
ABT Dec	$20.9B	$27.4B	$30.6B	$31.9B	$34.6B	$43.1B	$43.7B	$40.1B	$42.0B	$44.3B
TMO Dec	$18.3B	$20.9B	$24.4B	$25.5B	$32.2B	$39.2B	$44.9B	$42.9B	$42.9B	$44.6B
LLY Dec	$21.2B	$20.0B	$21.5B	$22.3B	$24.5B	$28.3B	$28.5B	$34.1B	$45.0B	$65.2B
AMGN Dec	$23.0B	$22.8B	$23.7B	$23.4B	$25.4B	$26.0B	$26.3B	$28.2B	$33.4B	$36.8B
MDT Apr	$28.8B	$29.7B	$30.0B	$30.6B	$28.9B	$30.1B	$31.7B	$31.2B	$32.4B	$33.5B
Peer median	$23.0B	$27.4B	$30.0B	$30.6B	$34.6B	$43.1B	$44.9B	$42.9B	$45.0B	$48.2B

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	+12.2%	+10.1%	+16.1%	+1.6%	+37.7%	+22.7%	+3.3%	−6.4%	+3.7%	+8.6%
MRK Dec	-	+0.8%	+5.4%	+10.7%	+6.1%	+17.3%	+21.7%	+1.4%	+6.7%	+1.3%
PFE Dec	-	−0.5%	+2.1%	+0.8%	+1.8%	+95.2%	+24.7%	−41.1%	+6.8%	−1.6%
HCA Dec	-	+5.1%	+7.0%	+10.0%	+0.4%	+14.0%	+2.5%	+7.9%	+8.7%	+7.1%
BMY Dec	+17.3%	+6.9%	+8.6%	+15.9%	+62.6%	+9.1%	−0.5%	−2.5%	+7.3%	−0.2%
ABT Dec	+2.2%	+31.3%	+11.6%	+4.3%	+8.5%	+24.5%	+1.3%	−8.1%	+4.6%	+5.7%
TMO Dec	+7.7%	+14.5%	+16.4%	+4.9%	+26.1%	+21.7%	+14.5%	−4.6%	+0.1%	+3.9%
LLY Dec	+6.3%	+7.8%	+7.6%	+3.8%	+9.9%	+15.4%	+0.8%	+19.6%	+32.0%	+44.7%
AMGN Dec	+6.1%	−0.6%	+3.9%	−1.6%	+8.8%	+2.2%	+1.3%	+7.1%	+18.6%	+10.0%
MDT Apr	-	+3.0%	+0.8%	+2.0%	−5.4%	+4.2%	+5.2%	−1.4%	+3.6%	+3.6%
Peer median	+6.3%	+5.1%	+7.0%	+4.3%	+8.5%	+15.4%	+2.5%	−1.4%	+6.8%	+3.9%

Gross margin, FY2016 to FY2025

Gross profit / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	-	-	-	-	-	-	-	-	-	-
MRK Dec	-	-	-	-	-	-	-	-	-	-
PFE Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	74.5%	70.7%	71.3%	69.1%	72.3%	-	-	-	-	-
ABT Dec	-	-	-	-	-	-	-	-	-	-
TMO Dec	-	-	-	-	-	-	-	-	-	-
LLY Dec	-	-	-	-	-	-	-	-	-	-
AMGN Dec	-	-	-	-	-	-	-	-	-	-
MDT Apr	68.3%	68.7%	69.8%	-	-	-	-	-	-	-
Peer median	-	-	-	-	-	-	-	-	-	-

Operating margin, FY2016 to FY2025

Operating income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	36.4%	33.8%	19.5%	39.0%	24.8%	31.9%	31.2%	23.5%	16.2%	24.6%
MRK Dec	-	-	-	-	-	-	-	-	-	-
PFE Dec	-	-	-	-	-	-	-	-	-	-
HCA Dec	-	-	-	-	-	-	-	-	-	-
BMY Dec	-	-	-	-	-	-	-	-	-	-
ABT Dec	14.5%	5.7%	11.9%	14.2%	15.5%	19.6%	19.2%	16.2%	16.3%	18.2%
TMO Dec	13.5%	14.2%	15.5%	18.0%	24.2%	25.6%	18.7%	16.0%	17.1%	17.4%
LLY Dec	-	-	-	-	-	-	-	-	-	-
AMGN Dec	42.6%	43.6%	43.2%	41.4%	35.9%	29.4%	36.3%	28.0%	21.7%	24.7%
MDT Apr	18.6%	18.1%	22.2%	20.5%	16.6%	14.9%	18.2%	17.6%	15.9%	17.8%
Peer median	16.6%	16.1%	18.8%	19.2%	20.4%	22.6%	18.9%	16.9%	16.7%	18.0%

Net margin, FY2016 to FY2025

Net income / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	23.2%	18.8%	17.4%	23.7%	10.1%	20.5%	20.4%	9.0%	7.6%	6.9%
MRK Dec	9.8%	6.0%	14.7%	25.2%	17.0%	26.8%	24.5%	0.6%	26.7%	28.1%
PFE Dec	13.7%	40.6%	27.3%	39.2%	22.0%	27.0%	31.0%	3.6%	12.6%	12.4%
HCA Dec	7.0%	5.1%	8.1%	6.8%	7.3%	11.8%	9.4%	8.1%	8.2%	9.0%
BMY Dec	22.9%	4.8%	21.8%	13.2%	−21.2%	15.1%	13.7%	17.8%	−18.5%	14.6%
ABT Dec	6.7%	1.7%	7.7%	11.6%	13.0%	16.4%	15.9%	14.3%	31.9%	14.7%
TMO Dec	11.1%	10.6%	12.1%	14.5%	19.8%	19.7%	15.5%	14.0%	14.8%	15.0%
LLY Dec	12.9%	−1.0%	15.0%	37.3%	25.2%	19.7%	21.9%	15.4%	23.5%	31.7%
AMGN Dec	33.6%	8.7%	35.3%	33.6%	28.6%	22.7%	24.9%	23.8%	12.2%	21.0%
MDT Apr	12.3%	13.6%	10.4%	15.2%	16.6%	12.0%	15.9%	12.0%	11.4%	13.9%
Peer median	12.3%	6.0%	14.7%	15.2%	17.0%	19.7%	15.9%	14.0%	12.6%	14.7%

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	$6.6B	$9.4B	$12.8B	$12.8B	$16.8B	$22.0B	$24.2B	$22.1B	$17.8B	$17.8B
MRK Dec	$8.8B	$4.6B	$8.3B	$10.1B	$5.8B	$8.7B	$14.7B	$9.1B	$18.1B	$12.4B
PFE Dec	$14.4B	$14.8B	$13.8B	$10.5B	$12.2B	$29.9B	$26.0B	$4.8B	$9.8B	$9.1B
HCA Dec	$2.9B	$2.4B	$3.2B	$3.4B	$6.4B	$5.4B	$4.1B	$4.7B	$5.6B	$7.7B
BMY Dec	$1.8B	$4.2B	$6.1B	$7.4B	$13.3B	$15.2B	$11.9B	$12.7B	$13.9B	$12.8B
ABT Dec	$2.1B	$4.4B	$4.9B	$4.5B	$5.7B	$8.6B	$7.8B	$5.1B	$6.4B	$7.4B
TMO Dec	$2.8B	$3.5B	$3.8B	$4.0B	$6.8B	$6.8B	$6.9B	$6.9B	$7.3B	$6.3B
LLY Dec	-	-	-	-	-	-	-	-	-	-
AMGN Dec	$9.6B	$10.5B	$10.6B	$8.5B	$9.9B	$8.4B	$8.8B	$7.4B	$10.4B	$8.1B
MDT Apr	$4.2B	$5.6B	$3.6B	$5.9B	$6.0B	$4.9B	$6.0B	$4.6B	$5.2B	$5.2B
Peer median	$3.5B	$4.5B	$5.5B	$6.6B	$6.6B	$8.5B	$8.3B	$6.0B	$8.6B	$7.9B

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	25.6%	33.4%	39.0%	38.4%	36.7%	39.1%	41.8%	40.6%	31.7%	29.1%
MRK Dec	22.0%	11.4%	19.6%	25.7%	14.0%	17.8%	24.8%	15.2%	28.2%	19.0%
PFE Dec	27.2%	28.3%	33.9%	25.8%	29.2%	36.7%	25.7%	8.0%	15.5%	14.5%
HCA Dec	7.0%	5.5%	6.8%	6.7%	12.4%	9.2%	6.9%	7.2%	8.0%	10.2%
BMY Dec	9.5%	20.3%	27.1%	28.2%	31.3%	32.8%	25.9%	28.1%	28.9%	26.7%
ABT Dec	10.0%	16.2%	16.0%	14.1%	16.5%	20.1%	17.9%	12.6%	15.1%	16.7%
TMO Dec	15.4%	16.7%	15.5%	15.8%	21.2%	17.3%	15.4%	16.2%	16.9%	14.1%
LLY Dec	-	-	-	-	-	-	-	-	-	-
AMGN Dec	41.8%	46.0%	44.5%	36.5%	38.9%	32.3%	33.4%	26.1%	31.1%	22.0%
MDT Apr	14.5%	18.9%	12.1%	19.2%	20.8%	16.2%	18.9%	14.7%	16.1%	15.5%
Peer median	14.9%	17.8%	17.8%	22.5%	21.0%	18.9%	21.8%	14.9%	16.5%	16.1%

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	128.4%	104.2%	n/m	n/m	35.3%	74.9%	68.6%	46.9%	128.7%	n/m
MRK Dec	9.8%	7.0%	23.3%	38.0%	27.9%	34.2%	31.6%	1.0%	37.0%	34.7%
PFE Dec	12.1%	29.9%	17.6%	25.4%	14.5%	28.5%	32.8%	2.4%	9.1%	9.0%
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
BMY Dec	27.6%	8.6%	35.1%	6.7%	−23.8%	19.5%	20.4%	27.3%	−54.8%	38.2%
ABT Dec	6.8%	1.5%	7.8%	11.9%	13.7%	19.8%	18.9%	14.8%	28.1%	12.5%
TMO Dec	9.4%	8.8%	10.7%	12.5%	18.5%	18.9%	15.8%	12.8%	12.8%	12.6%
LLY Dec	19.5%	−1.8%	32.9%	n/m	109.8%	62.2%	58.6%	48.6%	74.2%	77.8%
AMGN Dec	25.8%	7.8%	67.2%	81.1%	77.2%	88.0%	179.0%	107.8%	69.6%	89.1%
MDT Apr	6.8%	8.0%	6.1%	9.2%	9.4%	7.0%	9.6%	7.3%	7.3%	9.7%
Peer median	10.9%	7.9%	20.4%	12.5%	16.5%	24.1%	26.0%	13.8%	20.4%	23.6%

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	7.95	7.33	n/m	n/m	6.50	4.93	3.66	5.72	n/m	n/m
MRK Dec	0.62	0.71	0.94	1.02	1.26	0.87	0.67	0.93	0.80	0.94
PFE Dec	0.62	0.61	0.64	0.81	0.07	0.49	0.37	0.81	0.72	0.75
HCA Dec	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m	n/m
BMY Dec	0.41	0.62	0.49	0.96	1.39	1.37	1.39	1.34	3.15	2.55
ABT Dec	1.07	0.90	0.64	0.58	0.57	0.50	0.46	0.38	0.30	0.25
TMO Dec	0.76	0.78	0.71	0.62	0.71	0.91	0.91	0.82	0.67	0.80
LLY Dec	0.74	1.09	0.99	5.80	2.90	1.86	1.53	2.35	2.37	1.54
AMGN Dec	1.16	1.40	2.71	3.09	3.51	4.97	10.64	10.37	10.23	6.31
MDT Apr	0.60	0.67	0.51	0.51	0.49	0.51	0.46	0.47	0.50	0.53
Peer median	0.68	0.75	0.68	0.89	0.98	0.89	0.79	0.88	0.76	0.87

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

Company	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
ABBV Dec	$3.63	$3.30	$3.66	$5.28	$2.72	$6.45	$6.63	$2.72	$2.39	$2.36
MRK Dec	$1.41	$0.87	$2.32	$3.81	$2.78	$5.14	$5.71	$0.14	$6.74	$7.28
PFE Dec	$1.17	$3.52	$1.87	$2.82	$1.63	$3.85	$5.47	$0.37	$1.41	$1.36
HCA Dec	$7.30	$5.95	$10.66	$10.07	$10.93	$21.16	$19.15	$18.97	$22.00	$28.33
BMY Dec	$2.65	$0.61	$3.01	$2.01	−$3.99	$3.12	$2.95	$3.86	−$4.41	$3.46
ABT Dec	$0.94	$0.27	$1.33	$2.06	$2.50	$3.94	$3.91	$3.26	$7.64	$3.72
TMO Dec	$5.09	$5.59	$7.24	$9.17	$15.96	$19.46	$17.63	$15.45	$16.53	$17.74
LLY Dec	$2.58	−$0.19	$3.13	$8.89	$6.79	$6.12	$6.90	$5.80	$11.71	$22.95
AMGN Dec	$10.24	$2.69	$12.62	$12.88	$12.31	$10.28	$12.11	$12.49	$7.56	$14.23
MDT Apr	$2.48	$2.89	$2.27	$3.41	$3.54	$2.66	$3.73	$2.82	$2.76	$3.61
Peer median	$2.58	$2.69	$3.01	$3.81	$3.54	$5.14	$5.71	$3.86	$7.56	$7.28

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out ABBV and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more →

Next Industry numbers →

Work on ABBV in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ABBV/export.csv") into a cell.